Endocrine‐disrupting chemicals alter the glucocorticoid and PPARγ pathways to promote hyperphagia, inflammation, adipocyte hyperplasia and hypertrophy, and obesity. This evidence concerns the gene PPARG and obesity due to melanocortin 4 receptor deficiency.